Robert M. Cohen

8.3k total citations
53 papers, 3.3k citations indexed

About

Robert M. Cohen is a scholar working on Psychiatry and Mental health, Cognitive Neuroscience and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Robert M. Cohen has authored 53 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Psychiatry and Mental health, 14 papers in Cognitive Neuroscience and 12 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Robert M. Cohen's work include Diabetes Management and Research (10 papers), Functional Brain Connectivity Studies (10 papers) and Alzheimer's disease research and treatments (8 papers). Robert M. Cohen is often cited by papers focused on Diabetes Management and Research (10 papers), Functional Brain Connectivity Studies (10 papers) and Alzheimer's disease research and treatments (8 papers). Robert M. Cohen collaborates with scholars based in United States, Canada and Czechia. Robert M. Cohen's co-authors include Trey Sunderland, John A. Matochik, Alan J. Zametkin, Monique Ernst, Dennis L. Murphy, Matthew C. Riddle, Daisy M. Pascualvaca, Peter H. Jons, Ned H. Kalin and David C. Goff and has published in prestigious journals such as American Journal of Psychiatry, Brain and Neurology.

In The Last Decade

Robert M. Cohen

52 papers receiving 3.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert M. Cohen United States 31 860 785 710 571 497 53 3.3k
Elena Sinforiani Italy 34 302 0.4× 864 1.1× 1.0k 1.4× 753 1.3× 501 1.0× 140 3.8k
Jogin H. Thakore United Kingdom 25 789 0.9× 428 0.5× 1.4k 2.0× 664 1.2× 209 0.4× 61 3.0k
Samarthji Lal Canada 37 851 1.0× 668 0.9× 1.4k 2.0× 590 1.0× 1.2k 2.5× 141 4.2k
Keming Gao United States 39 348 0.4× 930 1.2× 2.3k 3.3× 627 1.1× 505 1.0× 138 4.8k
Steven M. Berman United States 32 222 0.3× 1.2k 1.5× 658 0.9× 696 1.2× 899 1.8× 62 3.5k
Renrong Wu China 33 467 0.5× 1.3k 1.7× 1.5k 2.1× 611 1.1× 202 0.4× 153 3.8k
Xiaoduo Fan United States 37 297 0.3× 697 0.9× 1.3k 1.9× 564 1.0× 236 0.5× 110 3.4k
Laurence Reed United Kingdom 22 293 0.3× 905 1.2× 261 0.4× 394 0.7× 842 1.7× 42 3.0k
Keijo Koivisto Finland 30 323 0.4× 488 0.6× 1.4k 1.9× 1.2k 2.2× 230 0.5× 63 3.4k
Daniel E. Casey United States 31 451 0.5× 267 0.3× 2.8k 3.9× 683 1.2× 721 1.5× 73 4.2k

Countries citing papers authored by Robert M. Cohen

Since Specialization
Citations

This map shows the geographic impact of Robert M. Cohen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert M. Cohen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert M. Cohen more than expected).

Fields of papers citing papers by Robert M. Cohen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert M. Cohen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert M. Cohen. The network helps show where Robert M. Cohen may publish in the future.

Co-authorship network of co-authors of Robert M. Cohen

This figure shows the co-authorship network connecting the top 25 collaborators of Robert M. Cohen. A scholar is included among the top collaborators of Robert M. Cohen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert M. Cohen. Robert M. Cohen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pfefferle, Petra Ina, Corinna U. Keber, Robert M. Cohen, & Holger Garn. (2021). The Hygiene Hypothesis – Learning From but Not Living in the Past. Frontiers in Immunology. 12. 635935–635935. 63 indexed citations
2.
Freedman, Barry I., Kaycee M. Sink, Christina E. Hugenschmidt, et al.. (2017). Associations of Early Kidney Disease With Brain Magnetic Resonance Imaging and Cognitive Function in African Americans With Type 2 Diabetes Mellitus. American Journal of Kidney Diseases. 70(5). 627–637. 28 indexed citations
3.
Papademetriou, Vasilios, Laura Lovato, Michael Doumas, et al.. (2014). Chronic kidney disease and intensive glycemic control increase cardiovascular risk in patients with type 2 diabetes. Kidney International. 87(3). 649–659. 140 indexed citations
4.
IsHak, Waguih William, et al.. (2013). Sexual Satisfaction and Quality of Life in Major Depressive Disorder Before and After Treatment With Citalopram in the STAR*D Study. The Journal of Clinical Psychiatry. 74(3). 256–261. 22 indexed citations
5.
6.
Fonseca, Vivian, Jorge Calles, Robert M. Cohen, et al.. (2013). Determinants of Weight Gain in the Action to Control Cardiovascular Risk in Diabetes Trial. Diabetes Care. 36(8). 2162–2168. 42 indexed citations
7.
Cohen, Robert M.. (2013). Epidemiology and Clinical Diagnosis. PET Clinics. 8(4). 391–405. 5 indexed citations
8.
Calles-Escandón, Jorge, Laura Lovato, Denise G. Simons‐Morton, et al.. (2010). Effect of Intensive Compared With Standard Glycemia Treatment Strategies on Mortality by Baseline Subgroup Characteristics. Diabetes Care. 33(4). 721–727. 123 indexed citations
9.
Riddle, Matthew C., Walter T. Ambrosius, David J. Brillon, et al.. (2010). Epidemiologic Relationships Between A1C and All-Cause Mortality During a Median 3.4-Year Follow-up of Glycemic Treatment in the ACCORD Trial. Diabetes Care. 33(5). 983–990. 292 indexed citations
10.
Filbey, Francesca M., et al.. (2006). Functional magnetic resonance imaging and magnetoencephalography differences associated with APOEε4 in young healthy adults. Neuroreport. 17(15). 1585–1590. 37 indexed citations
11.
12.
Ernst, Monique, Alan J. Zametkin, John A. Matochik, et al.. (1999). High Midbrain [18F]DOPA Accumulation in Children With Attention Deficit Hyperactivity Disorder. American Journal of Psychiatry. 156(8). 1209–1215. 196 indexed citations
13.
Ernst, Monique, Alan J. Zametkin, Peter H. Jons, et al.. (1999). High Presynaptic Dopaminergic Activity in Children With Tourette's Disorder. Journal of the American Academy of Child & Adolescent Psychiatry. 38(1). 86–94. 78 indexed citations
14.
Cohen, Robert M.. (1999). The Brain Metabolic Patterns of Clozapine- and Fluphenazine-Treated Female Patients with Schizophrenia Evidence of a Sex Effect. Neuropsychopharmacology. 21(5). 632–640. 21 indexed citations
15.
Wolkowitz, Owen M., et al.. (1988). Single-dose naloxone acutely reduces eating in obese humans: Behavioral and biochemical effects. Biological Psychiatry. 24(4). 483–487. 23 indexed citations
16.
Cohen, Robert M., William E. Semple, & Michael Groß. (1986). Positron Emission Tomography. Psychiatric Clinics of North America. 9(1). 63–79. 13 indexed citations
17.
Sunderland, Trey, Edward A. Mueller, Robert M. Cohen, David C. Jimerson, & David Pickar. (1985). Tyramine pressor sensitivity changes during deprenyl treatment. Psychopharmacology. 86(4). 432–437. 73 indexed citations
18.
Clark, Campbell, Richard E. Carson, R. Kessler, et al.. (1985). Alternative Statistical Models for the Examination of Clinical Positron Emission Tomography/Fluorodeoxyglucose Data. Journal of Cerebral Blood Flow & Metabolism. 5(1). 142–150. 92 indexed citations
19.
Cohen, Misha, Robert M. Cohen, D. Pickar, D.L. Murphy, & W.E. Bunney. (1983). Physiological Effects of High Dose Naloxone Administration to Normal Adults. Survey of Anesthesiology. 27(2). 75–75. 2 indexed citations
20.
Risch, S. Craig, Robert M. Cohen, David S. Janowsky, et al.. (1981). Physostigmine induction of depressive symptomatology in normal human subjects. Psychiatry Research. 4(1). 89–94. 90 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Elena Sinforiani Breakdown of academic impact, for papers by Jogin H. Thakore Breakdown of academic impact, for papers by Samarthji Lal Breakdown of academic impact, for papers by Keming Gao Breakdown of academic impact, for papers by Steven M. Berman Breakdown of academic impact, for papers by Renrong Wu Breakdown of academic impact, for papers by Xiaoduo Fan Breakdown of academic impact, for papers by Laurence Reed Breakdown of academic impact, for papers by Keijo Koivisto Breakdown of academic impact, for papers by Daniel E. Casey
Rankless by CCL
2026